Le LIRAES est co-leader d’un projet européen de l’Innovative Medicines Initiative
SPRINTT
Sarcopenia and physical frailty in older people : multi‐component treatment strategies
Summary
Frailty has a dramatic impact on the quality of life of many elderly people; the frail are at greater risk of falls and disability, and are more likely to be hospitalised. But what is frailty, and can it be prevented? The ultimate aim of the IMI project SPRINTT is to improve elderly people’s quality of life by paving the way towards a treatment for frailty. The project will do this by identifying the specific characteristics of frailty and testing whether frailty can be prevented by a treatment programme that combines exercise, dietary advice, and the use of modern technologies.
